Search clinical trials for: Vorapaxar and Aspirin

Total 271705 results

Inova Health Care Services
Merck Sharp & Dohme LLC

Completed

Vorapaxar on Thrombin Generation and Coagulability

Myocardial Infarction | Coronary Artery Disease | Peripheral Vascular Disease

United States
Merck Sharp & Dohme LLC

Completed

Trial to Assess the Safety of Vorapaxar in Japanese Subjects With Cerebral Infarction (P05005; MK-5348-017)

Cerebral Infarction
Ken Mahaffey
Merck Sharp & Dohme LLC

Completed

Vorapaxar Study for Maturation of AV Fistulae for Hemodialysis Access

AV Fistula

United States
Kirby Institute
National Institute of Allergy and Infectious Diseases (NIAID); Merck Sharp... and other collaborators

Completed

Attenuation of D-dimer Using Vorapaxar to Target Inflammatory and Coagulation Endpoints (ADVICE)

HIV

Australia, United States
Merck Sharp & Dohme LLC
Duke Clinical Research Institute; The TIMI (Thrombolysis in Myocardial Infarction)...

Completed

Trial to Assess the Ocular Safety of Vorapaxar (SCH 530348) in Participants With Atherosclerosis (Study P05183)

Myocardial Infarction | Ischemia | Atherosclerosis | Cerebrovascular Accident
Merck Sharp & Dohme LLC
The Thrombolysis in Myocardial Infarction Study (TIMI) Group

Completed

Trial to Assess the Effects of Vorapaxar (SCH 530348; MK-5348) in Preventing Heart Attack and Stroke in Patients With Atherosclerosis (TRA 2°P - TIMI 50) (P04737)

Myocardial Infarction | Ischemia | Peripheral Arterial Disease | Atherosclerosis | Cerebrovascular Accident
Merck Sharp & Dohme LLC

Completed

Safety of SCH 530348 in Subjects Undergoing Non-Emergent Percutaneous Coronary Intervention (Study P03573)

Coronary Disease | Arterial Obstructive Diseases
Vanderbilt University
Merck Sharp & Dohme LLC

Withdrawn

Vorapaxar and Lower Extremity Bypass Grafts

Peripheral Artery Disease
North Texas Veterans Healthcare System

Unknown

Excellence In Peripheral Artery Disease Thrombin Receptor Antagonist Intervention In Claudication Evaluation (XLPAD-TRACE Trial) (XLPADTRACE)

Peripheral Arterial Disease

United States
Merck Sharp & Dohme LLC
Duke Clinical Research Institute

Terminated

Trial to Assess the Effects of Vorapaxar (SCH 530348; MK-5348) in Preventing Heart Attack and Stroke in Particpants With Acute Coronary Syndrome (TRA•CER) (Study P04736)

Myocardial Infarction | Myocardial Ischemia | Atherosclerosis
CeloNova BioSciences, Inc.
ClinLogix. LLC

Terminated

COBRA SHIELD OCT Study

Stable Angina

Finland
Medical University of Vienna

Completed

Vorapaxar in the Human Endotoxemia Model

Healthy Volunteers

Austria
Barbara Ann Karmanos Cancer Institute
National Cancer Institute (NCI)

Completed

Arsenic Trioxide and Ascorbic Acid Combined With Bortezomib, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia

Multiple Myeloma and Plasma Cell Neoplasm

United States
Aswan University Hospital

Unknown

Aspirin for Prevention of Preeclampsia

Preeclampsia

Egypt
Federico II University

Completed

Platelet Aggregation in Diabetic Patients With Acute Coronary Syndrome Treated With Different Doses of Aspirin (DIABE-ASACS)

Diabetes Mellitus | Acute Coronary Syndrome

Italy
The First Affiliated Hospital with Nanjing Medical...

Unknown

the Efficacy and Safety of Indobufen and Low-dose Aspirin in Different Regimens of Antiplatelet Therapy

Coronary Atherosclerosis

China
University Hospital, Basel, Switzerland

Withdrawn

Prospective Double-blind Study for the Use of Aspirin During Transurethral Surgery of the Bladder or the Prostate

Blood Loss, Surgical | Intraoperative Complications | Re-operation Rates in Patients With Aspirin Treatment

Switzerland
Seoul National University Hospital
CKD Pharmaceutical Limited

Completed

Efficacy and Tolerability of Clopidogrel Resinate and Clopidogrel Bisulfate in Patients With Coronary Heart Disease (CHD) or CHD Equivalents

Coronary Heart Disease
University of Florida
Merck Sharp & Dohme LLC

Completed

Vorapaxar as an Add-On Antiplatelet Therapy in Patients With and Without Diabetes Mellitus (OPTIMUS-5)

Myocardial Infarction | Diabetes Mellitus | Peripheral Arterial Disease

United States
Queen Mary University of London
Cancer Research UK; Barts and the London School of Medicine and Dentistry

Completed

A Study to Examine the Effectiveness of Aspirin and/or Vitamin D3 to Prevent Prostate Cancer Progression (PROVENT)

Prostate Cancer

United Kingdom
Merck Sharp & Dohme LLC

Completed

Trial to Assess the Safety and Effects of Vorapaxar in Japanese Subjects With Acute Coronary Syndrome (P04772; MK-5348-016)

Myocardial Infarction | Myocardial Ischemia | Atherosclerosis
Merck Sharp & Dohme LLC

Completed

A Bioequivalence Study of SCH 530348 2.5 mg Tablets (P06558)

Acute Coronary Syndrome
FANG HE

Recruiting

Aspirin Discontinuation in High-Risk Pregnant Women of Preeclampsia

Preeclampsia | Perinatal Haemorrhage

China
University of Vigo

Recruiting

Chronotherapy With Low-dose Aspirin for Primary Prevention (CARING)

Type 2 Diabetes

Spain
Seoul National University Hospital

Completed

Effects of Low Dose Aspirin Pre-treatment on Platelet Activation Undergoing Off-pump Coronary Artery Bypass Surgery

Coronary Artery Disease

Korea, Republic of
Johns Hopkins University
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

Trial to Determine Effective Aspirin Dose in COPD

Pulmonary Disease, Chronic Obstructive

United States
Codman & Shurtleff

Terminated

VISSIT Intracranial Stent Study for Ischemic Therapy (VISSIT)

Ischemic Stroke | Transient Ischemic Attack
Seoul National University Hospital

Completed

The Effect of Celecoxib on the Antiplatelet Effect of Aspirin and Clopidogrel in Normal Volunteers

Healthy

Korea, Republic of
University of Florida
Merck Sharp & Dohme LLC

Completed

Vorapaxar in Patients With Prior Myocardial Infarction Treated With Prasugrel and Ticagrelor (VORA-PRATIC)

Myocardial Infarction

United States
PLx Pharma

Completed

Pharmacodynamic Evaluation of PL2200 Versus Enteric-Coated and Immediate Release Aspirin in Diabetic Patients

Diabetes Mellitus, Type 2

United States
BioSight Ltd.

Recruiting

A Phase I/II Dose Escalation and Expansion Study of BST-236 Plus Venetoclax in Patients With Unfit Newly Diagnosed AML

AML, Adult

United States
Bayer

Completed

Pharmacokinetic Study Comparing Aspirin and Effervescent Aspirin

Pharmacokinetics

United States
Boehringer Ingelheim

Completed

Modified-release Dipyridamole/Aspirin (200mg/25mg bd) Versus Aspirin (75mg) in Aspirin-resistant Patients

Coronary Arteriosclerosis

Ireland
All India Institute of Medical Sciences, New Delhi

Unknown

Effect of CPAP on Biomarkers in Patients With OSA (CPAP)

Obstructive Sleep Apnea

India
Bayer

Completed

Study to Evaluate How Patients Regard the Benefits and Risks of Low-dose Aspirin for the Prevention of Heart and Blood Vessels Disease and for the Prevention of Cancer of the Colon and Rectum

Cardiovascular Disease | Colorectal Cancer

Italy
University of Aarhus

Suspended

Clinical Trial Studying the Effects of Spironolactone on Heart and Skeletal Muscle Function in Chronic Alcoholics (SPICA)

Alcoholism | Cardiomyopathy, Alcoholic

Denmark
Vita Green Health Products Co. Ltd

Not yet recruiting

Pharmacokinetic and Pharmacodynamic Study of a Novel Sublingual Aspirin Tablet

Cardiovascular Diseases
NYU Langone Health

Recruiting

Body Weight, Aspirin Dose and Pro-resolving Mediators

Body Weight

United States
Seung-Jung Park
CardioVascular Research Foundation, Korea

Completed

Association of Clopidogrel Therapy and Stent Thrombosis (REAL-LATE)

Coronary Artery Disease

Korea, Republic of
Seung-Jung Park
CardioVascular Research Foundation, Korea

Completed

Duration of Clopidogrel Therapy After Drug-Eluting Stent (DES-LATE) (DES-LATE)

Coronary Artery Disease

Korea, Republic of
Xijing Hospital
Xi'an Central Hospital; Shaanxi Provincial People's Hospital; Tang-Du Hospital; Baoji Central Hospital and other collaborators

Recruiting

Low-dose Aspirin Therapy in Patients With Ischemic Stroke and Microbleeds (AIM)

Ischemic Stroke

China
The University of Texas Health Science Center,...

Completed

Effectiveness of Higher Aspirin Dosing for Prevention of Preeclampsia in High Risk Obese Gravida (ASPREO)

Obesity | Pre-Eclampsia | Hypertension in Pregnancy

United States
University of Utah

Completed

Metabolomic and Inflammatory Effects of Oral Aspirin (ASA) in Subjects at Risk for Melanoma

Melanoma (Skin)

United States
Associations for Establishment of Evidence in Interventions

Completed

Nobori Dual Antiplatelet Therapy as Appropriate Duration

Coronary Artery Disease

Japan
Assistance Publique - Hôpitaux de Paris
Bayer

Active, not recruiting

Aspirin Twice a Day in Patients With Diabetes and Acute Coronary Syndrome (ANDAMAN)

Coronary Artery Disease | Obesity | Diabetes Mellitus | Acute Coronary Syndrome

France
Washington University School of Medicine
Merit Medical Systems, Inc.

Completed

Management of Malignant Pleural Effusions Using an Indwelling Tunneled Pleural Catheter and Non-Vacuum Collection System

Malignant Pleural Effusion

United States
Beijing Anzhen Hospital

Unknown

GaStroEsophageal effeCt of indobUfen Versus aspiRin in Patients Undergoing Dual antiplatElet Therapy (SECURE)

Coronary Artery Disease | Gastroesophageal Reflux Disease

China
Svendborg Hospital
Takeda; Region of Southern Denmark

Unknown

Inhibition of Aldosterone to Reduce Myocardial Diffuse Fibrosis in Patients With Paroxysmal and Persistent Atrial Fibrillation in Preventing Recurrent Episodes of Atrial Fibrillation (INSPIRE-AF)

Atrial Fibrillation

Denmark
Loma Linda University

Recruiting

Stroke Rate in Patients With Blunt Cerebrovascular Injury (BCVI) Treated With Oral Acetylsalicylic Acid (ASA) 81 mg Versus ASA 325 mg (BASA). (BASA)

Blunt Cerebrovascular Injury

United States
Rhoshan Pharmaceuticals Inc

Completed

Comparative Pharmacokinetic, Pharmacodynamic, and Safety Study of 1 Dose Level of Aspirin for Injection and Oral Aspirin Tablets in Healthy Adult Human Subjects

Healthy

United States

Search clinical trials for: Vorapaxar and Aspirin

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ethiopia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations